bioRxivNeurosciencePreprint
Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice
Nan WangiD, Shasha Zhang, Peter LangfelderiD, Lalini RamanathaniD, Mary Plascencia, Fuying GaoiD, Raymond VacaiD, Xiaofeng GuiD, Linna Deng, Leonardo E. DionisioiD, Brinda C. PrasadiD, Thomas VogtiD, Steve HorvathiD, Jeffrey S. Aaronson, Jim Rosinski, X. William YangiD
Abstract
Modifiers of Huntingtons disease (HD) include mismatch repair (MMR) genes; however, their underlying disease-altering mechanisms remain unresolved. Knockout (KO) alleles for 9 HD GWAS modifiers/MMR genes were crossed to the Q140 Huntingtin (mHtt) knock-in mice to probe such mechanisms. Four KO mice strongly (Msh3 and Pms1) or moderately (Msh2 and Mlh1) rescue a triad of adult-onset, striatal medium-spiny-neuron (MSN)-selective phenotypes: somatic Htt DNA CAG-repeat expansion, transcriptionopathy, and mHtt protein aggregation. Comparatively, Q140 cortex also exhibits an analogous, but later-onset, pathogenic triad that is Msh3-dependent. Remarkably, Q140/homozygous Msh3-KO lacks visible mHtt aggregates in the brain, even at advanced ages (20-months). Moreover, Msh3-deficiency prevents striatal synaptic marker loss, astrogliosis, and locomotor impairment in HD mice. Purified Q140 MSN nuclei exhibit highly linear age-dependent mHtt DNA repeat expansion (i.e. repeat migration), with modal-CAG increasing at +8.8 repeats/month (R2=0.98). This linear rate is reduced to 2.3 and 0.3 repeats/month in Q140 with Msh3 heterozygous and homozygous alleles, respectively. Our study defines somatic Htt CAG-repeat thresholds below which there are no detectable mHtt nuclear or neuropil aggregates. Mild transcriptionopathy can still occur in Q140 mice with stabilized Htt 140-CAG repeats, but the majority of transcriptomic changes are due to somatic repeat expansion. Our analysis reveals 479 genes with expression levels highly correlated with modal-CAG length in MSNs. Thus, our study mechanistically connects HD GWAS genes to selective neuronal vulnerability in HD, in which Msh3 and Pms1 set the linear rate of neuronal mHtt CAG-repeat migration to drive repeat-length dependent pathogenesis; and provides a preclinical platform for targeting these genes for HD suppression across brain regions. One Sentence SummaryMsh3 and Pms1 are genetic drivers of sequential striatal and cortical pathogenesis in Q140 mice by mediating selective CAG-repeat migration in HD vulnerable neurons.
- Citations
- 13
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease
Sarah G. Aldous, Edward J. Smith, … Gillian P. Bates·BrainPeer-reviewed·Feb 21, 2024
- Somatic CRISPR editing of Msh3 mitigates Huntington's disease pathology in mice
Esaria Oliver, Marina V. Kovalenko, … Vanessa Chantal Wheeler·bioRxiv·Jun 10, 2026
- Loss of interruption in the HTT CAG repeat is associated with increased somatic expansion and loss of medium spiny neurons in HD
Chris Kay, Jessica Q. Dawson, … Michael R. Hayden·bioRxiv·Mar 5, 2026
- Di-valent siRNA Mediated Silencing of MSH3 Blocks Somatic Repeat Expansion in Mouse Models of Huntington's Disease
Daniel O’Reilly, Jillian Belgrad, … Anastasia Khvorova·Molecular TherapyPeer-reviewed·May 11, 2023
- Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington's disease
Ross Ferguson, Robert Goold, … Sarah J. Tabrizi·bioRxiv·Dec 5, 2023
- Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion
Rob Goold, Jasmine Donaldson, … Sarah J. Tabrizi·NAR Molecular MedicinePeer-reviewed·Mar 30, 2026